Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cellular Biomedicine Group Inc (NASDAQ:CBMG)

7.90
Delayed Data
As of Jun 23
 -0.40 / -4.82%
Today’s Change
5.05
Today|||52-Week Range
15.68
-39.69%
Year-to-Date
No recent news for Cellular Biomedicine Group Inc.

Today’s Trading

Previous close8.30
Today’s open8.35
Day’s range7.75 - 8.65
Volume1,070,356
Average volume (3 months)48,364
Market cap$112.9M
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-22.94%
Earnings growth (this year)+16.27%
Earnings growth (next 5 years)--
Revenue growth (last year)-74.94%
P/E ratioNM
Price/Sales281.79
Price/Book1.71

Competitors

 Today’s
change
Today’s
% change
--Wang On Group Ltd-0.00-14.29%
ADVMAdverum Biotechnolog...-0.10-3.51%
PLXProtalix Biotherapeu...+0.01+1.22%
PFNXPfenex Inc-0.39-8.07%
Data as of 4:11pm ET, 06/23/2017

Financials

Next reporting dateAugust 30, 2017
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$627.9K
Annual profit (last year)-$28.2M
Net profit margin-4,492.28%

Profile

Sector
Health Technology
Industry
Biotechnology
Director, Chief Executive &
Financial Officer
Bizuo Liu
Senior Vice President-
Clinical Development
Cheng Xiang Dai
Corporate headquarters
Cupertino, California

Forecasts